Robert Fishman
2020
In 2020, Robert Fishman earned a total compensation of $3.3M as Chief Medical Officer at 4D Molecular Therapeutics.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $44,875 |
| Option Awards | $3,155,179 |
| Salary | $89,749 |
| Total | $3,339,803 |
Fishman received $3.2M in option awards, accounting for 94% of the total pay in 2020.
Fishman also received $50K in bonus, $44.9K in non-equity incentive plan and $89.7K in salary.
Rankings
In 2020, Robert Fishman's compensation ranked 3,488th out of 13,090 executives tracked by ExecPay. In other words, Fishman earned more than 73.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,488 out of 13,090 | 73rd |
Division Manufacturing | 1,364 out of 5,624 | 76th |
Major group Chemicals And Allied Products | 512 out of 2,257 | 77th |
Industry group Drugs | 445 out of 1,957 | 77th |
Industry Biological Products, Except Diagnostic Substances | 109 out of 411 | 74th |
Source: SEC filing on April 6, 2021.
Fishman's colleagues
We found two more compensation records of executives who worked with Robert Fishman at 4D Molecular Therapeutics in 2020.